Drug Information

Drug General Information
Drug ID
D0M1ON
Former ID
DNCL002076
Drug Name
SHP-141
Indication Cutaneous T-cell lymphoma [ICD9: 202.1, 202.2; ICD10:C84.0, C84.1] Phase 1 [523985]
Company
Leukemia & Lymphoma Society; Shape Pharmaceuticals
Structure
Download

3D MOL
Target and Pathway
Target(s) Histone deacetylase Target Info Modulator [550476]
References
Ref 523985ClinicalTrials.gov (NCT01646567) SHP-141C in Plaque Type Psoriasis. U.S. National Institutes of Health.
Ref 550476National Cancer Institute Drug Dictionary (drug id 703816).